戻る Agenda
SESSION 5: SPECIAL ISSUES
Session Chair(s)
Mette Due Theilade Thomsen, PHD
CEO
PIP Adviser, Denmark
- Paediatric pharmaceutical forms and formulations
- Non-clinical studies to support paediatric development
- Paediatric clinical studies – specific issues : PK / PD in children; orphan drugs; newborns / neonates
Speaker(s)
Paediatric pharmaceutical forms and formulations
Mette Due Theilade Thomsen, PHD
PIP Adviser, Denmark
CEO